慢性异常性便秘患者的放射性监督肠道管理计划结果
Alfredo Domínguez-Muñoz1, Andrea Bischoff1, Lea A Wehrli1
1Department of Surgery, Division of Pediatric Surgery, International Center for Colorectal and Urogenital Care at Children's Hospital Colorado, Universtity of Colorado, 13213 E 16th Ave, Anschutz Medical Campus, Box 323, Aurora, CO, 80045, USA.
Pediatric surgery international
|July 10, 2023
概括
我们的放射性监督肠道管理计划 (RS-BMP) 有效地治疗慢性异常性便秘 (CIC). 这个程序取得了96%的成功率,利用Senna和阴囊,与行为障碍和巨肠影响的结果.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 结肠直肠手术 结肠直肠手术
- 放射学 放射学是一门学科.
背景情况:
- 慢性异常性便秘 (CIC) 显著影响儿童的生活质量.
- 以前对CIC的治疗方法经常失败,需要先进的管理策略.
- 放射学监督的方法提供了一个结构化的方法来管理复杂的儿科便秘.
研究的目的:
- 评估放射性监督肠道管理计划 (RS-BMP) 对患有CIC的儿科患者的有效性.
- 在RS-BMP中识别与治疗成功或失败相关的因素.
主要方法:
- 在2016年7月至2022年10月期间接受治疗的80名患有CIC的儿科患者的回顾性分析.
- 审查治疗史,包括先前的治疗和手术干预.
- 评估结果,包括成功率,药物使用,以及巨肠和行为障碍的存在.
主要成果:
- 该RS-BMP在治疗CIC时表现出96%的成功率.
- 在成功的病例中,Senna (73%) 和阴囊 (27%) 是主要使用的治疗方法.
- 在成功 (93%) 和不成功 (100%) 的结局中,大肠是普遍存在的,而行为障碍与较差的结局 (11%的不成功) 有关.
结论:
- RS-BMP是治疗儿科慢性异常性便秘的高效疗法.
- 在放射学监督下,Senna和阴囊是成功治疗的关键组成部分.
- 行为障碍和巨肠与CIC的治疗挑战有关.
相关概念视频
01:21Drugs for Treatment of Constipation-Predominant IBS
219
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
219
01:21Inflammatory Bowel Disease V: Surgical Management
171
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
171
01:17Chronic Bowel Disorders: Introduction
489
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
489
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
244
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
244
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
357
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
357
01:17Drugs for Treatment of Diarrhea-Predominant IBS
217
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
217